Blueprint Medicines Corp
Pharmaceutical company · Cambridge, Massachusetts, United States
Blueprint Medicines Corp is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2014.
Blueprint Medicines at a glance
What does Blueprint Medicines do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $50 million sold (2014).
Frequently asked questions about Blueprint Medicines
Where is Blueprint Medicines headquartered?
Blueprint Medicines Corp is headquartered in Cambridge, Massachusetts, United States.
What does Blueprint Medicines do?
Blueprint Medicines Corp is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.